BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33046409)

  • 21. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
    Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma.
    Tuchman SA; Moore JO; DeCastro CD; Li Z; Sellars E; Kang Y; Long G; Gasparetto CG
    J Geriatr Oncol; 2017 May; 8(3):165-169. PubMed ID: 28256432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.
    Bao L; Wang YT; Liu P; Lu MQ; Zhuang JL; Zhang M; Xia ZJ; Li ZL; Yang Y; Yan ZY; Jing HM; Dong F; Chen WM; Wu Y; Zhou HB; Fu R; Gong YP; Huang WR; Zhang YQ
    EClinicalMedicine; 2024 Feb; 68():102431. PubMed ID: 38318126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.
    Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV
    Blood; 2015 Mar; 125(13):2068-74. PubMed ID: 25628469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Electronic Frailty Index is Associated with Increased Infection and All-Cause Mortality Among Older Patients with Primary Lung Cancer: A Cohort Study.
    Shen Y; Wang Y; Shi Q; Hou L; Chen X; Dong B; Hao Q
    Clin Interv Aging; 2021; 16():1825-1833. PubMed ID: 34675497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence.
    Holler M; Ihorst G; Reinhardt H; Rösner A; Braun M; Möller MD; Dreyling E; Schoeller K; Scheubeck S; Wäsch R; Engelhardt M
    Haematologica; 2023 Apr; 108(4):1115-1126. PubMed ID: 36325890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of treatment outcomes and tolerability in older patients with rectal cancer treated with radiotherapy accompanied by the G-8 geriatric score: TROD13-003 multicenter study.
    Güzelöz Z; Görken İB; Aydın B; Sert F; Yalman D; Parvizi M; Avcı GG; Altınok P; Halis H; Ergen ŞA; Akgün Z; Özkan E; Güney Y; Karaçetin D; Kaydıhan N; Düzova M; Akın M; Uysal B; Erdoğan M; Ellidokuz H; Aksu G; Metcalfe E
    J Geriatr Oncol; 2024 Apr; 15(3):101739. PubMed ID: 38492350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer.
    Narasimhulu DM; McGree ME; Weaver AL; Jatoi A; LeBrasseur NK; Glaser GE; Langstraat CL; Block MS; Kumar A
    Gynecol Oncol; 2020 Sep; 158(3):646-652. PubMed ID: 32518016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Haemato-Oncology Frailty (HOF) score to assess frailty in lymphoma.
    Ramdany H; Lofaro T; Deplano S
    Eur J Haematol; 2024 Apr; 112(4):611-620. PubMed ID: 38112247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
    Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
    Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
    Mian H; Wildes TM; Vij R; Pianko MJ; Major A; Fiala MA
    Blood Cancer J; 2023 May; 13(1):76. PubMed ID: 37164972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
    Lee HS; Kim K; Kim SJ; Lee JJ; Kim I; Kim JS; Eom HS; Yoon DH; Suh C; Shin HJ; Mun YC; Kim MK; Lim SN; Choi CW; Kang HJ; Yoon SS; Min CK;
    Am J Hematol; 2020 Apr; 95(4):413-421. PubMed ID: 31919872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival.
    Schneider M; Potthoff AL; Scharnböck E; Heimann M; Schäfer N; Weller J; Schaub C; Jacobs AH; Güresir E; Herrlinger U; Vatter H; Schuss P
    J Neurooncol; 2020 Sep; 149(3):421-427. PubMed ID: 32989681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple.
    Schütz NP; Ochoa P; Duarte P; Remaggi G; Yantorno S; Corzo A; Zabaljauregui S; Shanley C; Lopresti S; Orlando S; Verri V; Quiroga L; García CA; Fernández V; Fantl D
    Hematol Oncol; 2020 Aug; 38(3):363-371. PubMed ID: 32196120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
    Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
    J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
    Sim S; Kalff A; Tuch G; Mollee P; Ho PJ; Harrison S; Gibbs S; Prince HM; Spencer A; Joshua D; Lee C; Ling S; Murphy N; Szabo F; Szer J; Weber N; Ward C; Talaulikar D; Zannettino A; Quach H
    Intern Med J; 2023 May; 53(5):819-824. PubMed ID: 36880355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma.
    Giri S; Dahal S; Bal S; Godby KN; Richman J; Olszewski AJ; Williams GR; Brown C; Buford TW; Costa LJ; Bhatia S
    J Geriatr Oncol; 2022 May; 13(4):486-492. PubMed ID: 34924305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review.
    Mian H; Brouwers M; Kouroukis CT; Wildes TM
    J Frailty Aging; 2019; 8(4):215-221. PubMed ID: 31637409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer.
    Guerard EJ; Deal AM; Chang Y; Williams GR; Nyrop KA; Pergolotti M; Muss HB; Sanoff HK; Lund JL
    J Natl Compr Canc Netw; 2017 Jul; 15(7):894-902. PubMed ID: 28687577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.